Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Does Not Result in Severe Cardiac Dysfunction
- 11 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (1) , 93-99
- https://doi.org/10.1161/hh0102.102757
Abstract
Nitric oxide (NO), a potent regulator of myocardial contractility, has been implicated in the development of heart failure; however, no study exists describing the relation between expression of in...Keywords
This publication has 29 references indexed in Scilit:
- NO and cardiac diastolic functionCardiovascular Research, 1999
- Transgenic Mice Overexpressing Type 2 Nitric-oxide Synthase in Pancreatic β Cells Develop Insulin-dependent Diabetes without InsulitisJournal of Biological Chemistry, 1998
- Tumor Necrosis Factorα(TNFα) is Cardiodepressant in Pathophysiologically Relevant Concentrations Without Inducing Inducible Nitric Oxide-(NO)-Synthase (iNOS) or Triggering Serious CytotoxicityJournal of Molecular and Cellular Cardiology, 1997
- Cytokines and Insulin Induce Cationic Amino Acid Transporter (CAT) Expression in Cardiac MyocytesJournal of Biological Chemistry, 1996
- Inducible nitric oxide synthase in the cardiovascular system.Heart, 1996
- Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.Heart, 1995
- In Vivo Definition of a Cardiac Specific Promoter and Its Potential Utility in Remodeling the HeartAnnals of the New York Academy of Sciences, 1995
- Nitric oxide and the pathogenesis of heart muscle diseaseEuropean Journal of Clinical Investigation, 1995
- Nitric oxide synthase activities in human myocardiumThe Lancet, 1993
- Isolation and characterization of argininosuccinate synthetase from human liverBiochemistry, 1979